Literature DB >> 17071826

Consequences of telomere shortening at an active VSG expression site in telomerase-deficient Trypanosoma brucei.

Oliver Dreesen1, George A M Cross.   

Abstract

Trypanosoma brucei evades the host immune response by sequential expression of a large family of variant surface glycoproteins (VSG) from one of approximately 20 subtelomeric expression sites (ES). VSG transcription is monoallelic, and little is known about the regulation of antigenic switching. To explore whether telomere length could affect antigenic switching, we created a telomerase-deficient cell line, in which telomeres shortened at a rate of 3 to 6 bp at each cell division. Upon reaching a critical length, short silent ES telomeres were stabilized by a telomerase-independent mechanism. The active ES telomere progressively shortened and frequently broke. Upon reaching a critical length, the short active ES telomere stabilized, but the transcribed VSG was gradually lost from the population and replaced by a new VSG through duplicative gene conversion. We propose a model in which subtelomeric-break-induced replication-mediated repair at a short ES telomere leads to duplicative gene conversion and expression of a new VSG.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17071826      PMCID: PMC1694812          DOI: 10.1128/EC.00059-06

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  39 in total

1.  Identification, purification and properties of clone-specific glycoprotein antigens constituting the surface coat of Trypanosoma brucei.

Authors:  G A Cross
Journal:  Parasitology       Date:  1975-12       Impact factor: 3.234

Review 2.  Why are parasite contingency genes often associated with telomeres?

Authors:  J D Barry; M L Ginger; P Burton; R McCulloch
Journal:  Int J Parasitol       Date:  2003-01       Impact factor: 3.981

3.  In situ analysis of a variant surface glycoprotein expression-site promoter region in Trypanosoma brucei.

Authors:  M Navarro; G A Cross
Journal:  Mol Biochem Parasitol       Date:  1998-07-01       Impact factor: 1.759

4.  TRF2 protects human telomeres from end-to-end fusions.

Authors:  B van Steensel; A Smogorzewska; T de Lange
Journal:  Cell       Date:  1998-02-06       Impact factor: 41.582

5.  Antigenic variation in clones of animal-infective Trypanosoma brucei derived and maintained in vitro.

Authors:  J J Doyle; H Hirumi; K Hirumi; E N Lupton; G A Cross
Journal:  Parasitology       Date:  1980-04       Impact factor: 3.234

6.  Growth of chromosome ends in multiplying trypanosomes.

Authors:  A Bernards; P A Michels; C R Lincke; P Borst
Journal:  Nature       Date:  1983 Jun 16-22       Impact factor: 49.962

7.  Genomic environment of the expression-linked extra copies of genes for surface antigens of Trypanosoma brucei resembles the end of a chromosome.

Authors:  T De Lange; P Borst
Journal:  Nature       Date:  1982-09-30       Impact factor: 49.962

8.  Position-dependent and promoter-specific regulation of gene expression in Trypanosoma brucei.

Authors:  D Horn; G A Cross
Journal:  EMBO J       Date:  1997-12-15       Impact factor: 11.598

9.  The molecular karyotype of the megabase chromosomes of Trypanosoma brucei and the assignment of chromosome markers.

Authors:  S E Melville; V Leech; C S Gerrard; A Tait; J M Blackwell
Journal:  Mol Biochem Parasitol       Date:  1998-08-01       Impact factor: 1.759

10.  Selection for activation of a new variant surface glycoprotein gene expression site in Trypanosoma brucei can result in deletion of the old one.

Authors:  G Rudenko; I Chaves; A Dirks-Mulder; P Borst
Journal:  Mol Biochem Parasitol       Date:  1998-09-01       Impact factor: 1.759

View more
  10 in total

Review 1.  DNA double-strand breaks and telomeres play important roles in trypanosoma brucei antigenic variation.

Authors:  Bibo Li
Journal:  Eukaryot Cell       Date:  2015-01-09

2.  A trans-spliced telomerase RNA dictates telomere synthesis in Trypanosoma brucei.

Authors:  Ranjodh Sandhu; Samantha Sanford; Shrabani Basu; Mina Park; Unnati M Pandya; Bibo Li; Kausik Chakrabarti
Journal:  Cell Res       Date:  2013-03-12       Impact factor: 25.617

3.  Telomere length in Trypanosoma brucei.

Authors:  Oliver Dreesen; George A M Cross
Journal:  Exp Parasitol       Date:  2007-08-29       Impact factor: 2.011

4.  Intrinsic DNA curvature in trypanosomes.

Authors:  Pablo Smircich; Najib M El-Sayed; Beatriz Garat
Journal:  BMC Res Notes       Date:  2017-11-09

Review 5.  Evaluation of mechanisms that may generate DNA lesions triggering antigenic variation in African trypanosomes.

Authors:  Marcelo Santos da Silva; Galadriel A Hovel-Miner; Emma M Briggs; Maria Carolina Elias; Richard McCulloch
Journal:  PLoS Pathog       Date:  2018-11-15       Impact factor: 6.823

6.  Telomere components as potential therapeutic targets for treating microbial pathogen infections.

Authors:  Bibo Li
Journal:  Front Oncol       Date:  2012-11-01       Impact factor: 6.244

7.  Telomere length affects the frequency and mechanism of antigenic variation in Trypanosoma brucei.

Authors:  Galadriel A Hovel-Miner; Catharine E Boothroyd; Monica Mugnier; Oliver Dreesen; George A M Cross; F Nina Papavasiliou
Journal:  PLoS Pathog       Date:  2012-08-30       Impact factor: 6.823

8.  A yeast-endonuclease-generated DNA break induces antigenic switching in Trypanosoma brucei.

Authors:  Catharine E Boothroyd; Oliver Dreesen; Tatyana Leonova; K Ina Ly; Luisa M Figueiredo; George A M Cross; F Nina Papavasiliou
Journal:  Nature       Date:  2009-04-15       Impact factor: 49.962

Review 9.  Antigenic variation in African trypanosomes: the importance of chromosomal and nuclear context in VSG expression control.

Authors:  Lucy Glover; Sebastian Hutchinson; Sam Alsford; Richard McCulloch; Mark C Field; David Horn
Journal:  Cell Microbiol       Date:  2013-10-10       Impact factor: 3.715

10.  Trypanosoma brucei TIF2 and TRF Suppress VSG Switching Using Overlapping and Independent Mechanisms.

Authors:  Sanaa E Jehi; Vishal Nanavaty; Bibo Li
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.